Related Experiment Video

Updated: Sep 1, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

Imaging features of toxicities associated with immune checkpoint inhibitors

Babina Gosangi1, Lacey McIntosh2, Abhishek Keraliya3

  • 1Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.

European Journal of Radiology Open
|August 15, 2022
PubMed

Keywords:
AIP, acute interstitial pneumonitisARDS, acute respiratory distress syndromeCTCAE, Common Terminology Criteria for Adverse EventsCTLA-4 inhibitor, Cytotoxic T-lymphocyte antigen- 4 inhibitorColitisFDA, Food and Drug AdministrationHepatitisICI, Immune check point inhibitorImmune check point inhibitors toxicityLGE, late Gadolinium enhancementNSCLC, non-small cell lung cancerNSIP, non-specific interstitial pneumoniaOP, organizing pneumoniaPD-1 inhibitor, programmed cell death-1 inhibitorPD-L1 inhibitor, programmed cell death ligand-1 inhibitorPFS, progression free survivalPancreatitisPneumonitisRRP, radiation recall pneumonitisirAE, immune-related adverse event

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
646
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.2K